BRIEF-Moody's says Teva's loss of two copaxone patents is credit negative
August 25, 2016 at 14:45 PM EDT
* Moody's on Teva Pharmaceutical - there is no change to Teva Pharmaceutical Industries LTD Baa2 senior unsecured rating or stable outlook Source text for Eikon:
